Septic arthritis of the native hip joint: a multi-pattern, multi-outcome disease
European Journal of Orthopaedic Surgery & Traumatology · 29.01.2023 · 33 (6) · 2587-2594
DOI: 10.1007/s00590-023-03477-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Orthopaedic Surgery & Traumatology, online erschienen am 29.01.2023. Verfasst von Byungseob Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical and Health Science, University of Auckland, Grafton, Auckland, New Zealand. bkim946@aucklanduni.ac.nz. Hauptthemen laut MEDLINE: Arthritis, Infectious. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAUL and its Member Institutions.
Abstract (Originalsprache)
Purpose
Septic arthritis of the native hip joint (SANH) is an uncommon surgical and medical emergency with few reports. The aim of this study was to determine predictors of return to theatre (RTT), complications and mortality.
Methods
Patients with SANH were identified from January 2009 to June 2022; 50 patients and three subgroups were identified: Pyogenic (surgical washout without systemic inflammatory disease), Systemic (surgical washout with SIDs) and patients managed non-surgically . Patterns of these groups were assessed with a principal component analysis. The cumulative incidences for death, any complication and RTT for repeat washout were calculated. The predictive variables associated with outcomes were selected with univariable models and then incorporated in multivariable CoxPH regressions.
Results
The 1-year cumulative incidence was 14% for mortality and 48.5% for any complication. Amongst patients managed surgically, 1-year risk of RTT was 46% in Pyogenic subgroup and 21% in Systemic subgroup. Systemic subgroup had lower complications and RTT and higher rate of sterile aspirate, compared to Pyogenic. Charlson comorbidity index (CCI) (HR = 1.41, P value = 0.03), preoperative albumin (HR = 0.81, P value = 0.009) and preoperative haemoglobin (HR = 0.95, P value = 0.02) were significantly associated with 1-year mortality. Time between symptom onset and admission > 7 days (HR = 3.15, P value = 0.042), preoperative Hb (HR = 1.05, P value = 0.016), socioeconomic deprivation (HR = 1.18, P value = 0.04) and Systemic subgroup (HR = 0.25, P value = 0.04) were significantly associated with RTT.
Conclusion
Mortality was well predicted by the usual parameters including CCI, albumin, but also low haemoglobin. Patients presenting in a delayed fashion were more likely to have multiple lavages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medical and Health Science, University of Auckland, Grafton, Auckland, New Zealand. bkim946@aucklanduni.ac.nz.
- Department of Orthopaedic Surgery, Waikato Hospital, Hamilton, New Zealand.
- ECAMO Team, CRESS, UMR1153, INSERM, Paris, France.
- Department of Rheumatology, Waikato Hospital, Hamilton, New Zealand.
- Department of Medicine, University of Auckland, Auckland, New Zealand.
- Department of Surgery, University of Auckland, Auckland, New Zealand.
Förderung
- CAUL and its Member Institutions
Zitieren
APA
Kim, B., Boukebous, B., White, D., & Baker, J. F. (2023). Septic arthritis of the native hip joint: a multi-pattern, multi-outcome disease. European Journal of Orthopaedic Surgery & Traumatology, 33(6), 2587-2594. https://doi.org/10.1007/s00590-023-03477-2
Vancouver
Kim B, Boukebous B, White D, Baker JF. Septic arthritis of the native hip joint: a multi-pattern, multi-outcome disease. European Journal of Orthopaedic Surgery & Traumatology. 2023;33(6):2587-2594. doi:10.1007/s00590-023-03477-2
BibTeX
@article{Kim2023,
author = {Kim, Byungseob and Boukebous, Baptiste and White, Douglas and Baker, Joseph F},
title = {Septic arthritis of the native hip joint: a multi-pattern, multi-outcome disease},
journal = {European Journal of Orthopaedic Surgery & Traumatology},
year = {2023},
volume = {33},
number = {6},
pages = {2587--2594},
doi = {10.1007/s00590-023-03477-2}
}
EUVIMED